Charles Schwab
VSTM icon

Charles Schwab’s Verastem VSTM Stock Holding History

Charles Schwab’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Buy
243,950
+47,449
+24% +$230K ﹤0.01% 3027
2026
Q1 		$1.04M Buy
196,501
+35,336
+22% +$218K ﹤0.01% 2897
2025
Q4 		$1.24M Buy
161,165
+17,772
+12% +$158K ﹤0.01% 2854
2025
Q3 		$1.27M Buy
143,393
+32
+0% +$238 ﹤0.01% 2877
2025
Q2 		$595K Buy
143,361
+25,577
+22% +$160K ﹤0.01% 3080
2025
Q1 		$710K Buy
117,784
+4,183
+4% +$25.6K ﹤0.01% 2961
2024
Q4 		$587K Buy
113,601
+10,000
+10% +$39.4K ﹤0.01% 3094
2024
Q3 		$310K Buy
103,601
+32,791
+46% +$89K ﹤0.01% 3276
2024
Q2 		$211K Buy
70,810
+59,651
+535% +$492K ﹤0.01% 3434
2024
Q1 		$132K Buy
+11,159
New +$129K ﹤0.01% 3283
2023
Q2 		– Sell
-7,159
Closed -$35.7K – 3686
2023
Q1 		$35.7K Hold
7,159
– – ﹤0.01% 3414
2022
Q4 		$34.6K Buy
7,159
+887
+14% +$4.36K ﹤0.01% 3430
2022
Q3 		$64K Hold
6,272
– – ﹤0.01% 3274
2022
Q2 		$88K Sell
6,272
-32,102
-84% -$511K ﹤0.01% 3300
2022
Q1 		$650K Buy
38,374
+924
+2% +$15.9K ﹤0.01% 3018
2021
Q4 		$922K Hold
37,450
– – ﹤0.01% 2948
2021
Q3 		$1.39M Buy
37,450
+2,363
+7% +$86.8K ﹤0.01% 2776
2021
Q2 		$1.71M Sell
35,087
-1,045
-3% -$43.6K ﹤0.01% 2766
2021
Q1 		$1.07M Buy
36,132
+2,663
+8% +$74.6K ﹤0.01% 2833
2020
Q4 		$856K Buy
33,469
+113
+0.3% +$2.27K ﹤0.01% 2818
2020
Q3 		$485K Hold
33,356
– – ﹤0.01% 2881
2020
Q2 		$689K Buy
+33,356
New +$882K ﹤0.01% 2734
2019
Q2 		– Sell
-11,975
Closed -$426K – 3267
2019
Q1 		$426K Sell
11,975
-957
-7% -$37.8K ﹤0.01% 2821
2018
Q4 		$522K Hold
12,932
– – ﹤0.01% 2752
2018
Q3 		$1.13M Buy
12,932
+3,401
+36% +$338K ﹤0.01% 2583
2018
Q2 		$787K Buy
+9,531
New +$583K ﹤0.01% 2654
2016
Q2 		– Sell
-3,317
Closed -$63K – 3137
2016
Q1 		$63K Hold
3,317
– – ﹤0.01% 3022
2015
Q4 		$75K Sell
3,317
-608
-15% -$14.4K ﹤0.01% 3057
2015
Q3 		$85K Hold
3,925
– – ﹤0.01% 3049
2015
Q2 		$356K Hold
3,925
– – ﹤0.01% 2804
2015
Q1 		$480K Buy
3,925
+1,425
+57% +$149K ﹤0.01% 2643
2014
Q4 		$275K Hold
2,500
– – ﹤0.01% 2879
2014
Q3 		$256K Hold
2,500
– – ﹤0.01% 2868
2014
Q2 		$272K Hold
2,500
– – ﹤0.01% 2897
2014
Q1 		$324K Hold
2,500
– – ﹤0.01% 2767
2013
Q4 		$342K Buy
2,500
+783
+46% +$103K ﹤0.01% 2739
2013
Q3 		$254K Hold
1,717
– – ﹤0.01% 2835
2013
Q2 		$292K Buy
+1,717
New +$207K ﹤0.01% 2740

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab's VSTM Position: Q2 2026 in Review

Charles Schwab increased its Verastem (VSTM) stake by 24% in Q2 2026, buying an estimated $230K and bringing the position to 243,950 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

Charles Schwab first reported a position in VSTM in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.71M in Q2 2021. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Charles Schwab held 243,950 shares of Verastem worth $932K as of Q2 2026.
  • Charles Schwab bought 47,449 Verastem shares in Q2 2026, an estimated $230K.
  • Verastem made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3027 holding.
  • Charles Schwab first reported a position in Verastem in Q2 2013 and has held it in 38 quarters since.
  • Charles Schwab's Verastem position peaked at $1.71M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.